Viking Therapeutics Nears Major Milestone for Game-Changing Oral Obesity Pill
Clinical Setback: Tvardi Therapeutics' Lung Disease Candidate Falls Short in Crucial Trial
Valneva's 2025 Outlook Takes a Hit as Key Vaccine Marketing Rights Shift in Brazil
Amneal Pharmaceuticals Eyes Major Market Entry with Xolair Biosimilar, Pledging Affordable Relief
Regeneron's Evkeeza Achieves Landmark FDA Approval, Extending Life-Saving Treatment to Youngest HoFH Patients
A Crushing Blow: Acadia Pharma's Prader-Willi Syndrome Trial Fails to Meet Endpoints
FDA Greenlights At-Home Leqembi: A Game-Changer for Early Alzheimer's Treatment